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As o f March 2009, 84 countries  and territorie s worldwide  support harm redu ction in pol icy or pra ctice.
74 have an explicit supportive reference to harm reduction in national policy documents 
77 have needle and syringe exchange 
10 have needle and syringe exchange in prisons
65 have opioid substitution therapy 
37 have opioid substitution therapy in prisons
8 have drug consumption rooms
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Guide to reading the table
Explicit supportive reference to harm reduction in national policy documents:
Needle and syringe exchange programmes operational: 
Opioid substitution therapy programmes operational: 
Drug consumption rooms (DCRs):
Needle exchange in prisons: 
Opioid substitution therapy in prisons: 
The table below lists the countries and territories around the world that support harm reduction in policy or practice.1
 Countries and territories which have an explicit reference to harm reduction in 
national health or drug-related policy. Of particular interest here is the US, which includes harm reduction in its national HIV2 and hepatitis C3 strategy documents, 
but not in those relating to drug policy. 
Countries and territories which have one or more operational NSP sites. 
Countries and territories which have one or more sites which provide opioid substitution therapy as 
maintenance (not for detoxification only).
 Countries and territories which have one or more operational DCRs (or safer injecting facilities)
Countries and territories which have one or more prisons with operational NSP  
Countries and territories which have one or more prisons with opioid substitution therapy as maintenance (not for 
detoxification only)
Please note that this listing does not indicate the scope, quality or coverage of services.
1 The data are largely  drawn from Cook C & Kanaef N (2008)  (International Harm 
Reduction Association, London). This document has been reviewed and updated in February 2009 by the International Harm Reduction Association, Eurasian Harm Reduction Network, Sub-
Saharan African Harm Reduction Network, International Harm Reduction Development Program of the Open Society Institute, Caribbean Harm Reduction Coalition, Middle East and North Africa 
Harm Reduction Network, European Monitoring Centre for Drugs and Drug Addiction. International HIV/AIDS Alliance (UK and Ukraine) and Intercambios Association Civ il. 
2 Centers for Disease Control and Prevention (2007) CDC HIV Prevention Strategic Plan: Extended Through 2010. Atlanta: CDC
3 Centers for Disease Control and Prevention (2001) National Hepatitis C Prevention Strategy. Atlanta: CDC
                                                
Global State of Harm Reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics
Country (
Explicit 
supportive 
reference to 
harm reduction 
in national policy 
documents
Needle and 
syringe 
exchange 
programmes 
operational
Opioid 
substitution 
therapy 
programmes 
operational
Drug 
consumption 
rooms
Needle exchange 
in prisons
Opioid 
substitution 
therapy in 
prisons
ASIA
CENTRAL AND EASTERN EUROPE AND 
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or territory)
Afghanistan
Bangladesh
Cambodia
China
India
Indonesia
PDR Laos
Malaysia
Maldives
Myanmar
Nepal
Pakistan
Philippines
Thailand
Vietnam
Albania
Armenia
Azerbaijan
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(Taiwan)
(Hong Kong Special Administrative Region)
Latv ia
Lithuania
Macedonia
Moldova
Montenegro
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Tajikistan
Ukraine
Uzbekistan
Argentina
Brazil
Colombia
Mexico
Paraguay
Uruguay
Egypt
Iran
Israel
Lebanon
Morocco
Oman
Canada
United States
Australia
New Zealand
Mauritius
South Africa
Tanzania
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LATIN AMERICA
MIDDLE EAST and NORTH AFRICA
NORTH AMERICA
OCEANIA
SUB-SAHARAN AFRICA
(Puerto Rico) nk
(Zanzibar)
WESTERN EUROPE
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Austria
Belgium
Cyprus
Denmark
Finland
France
Germany
Greece
Ireland
Italy
Luxembourg
Malta
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
United Kingdom
– International Harm Reduction Association, March 2009
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